Citation Impact
Citing Papers
Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons
2008 StandoutScience
Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis
2002
Morphological, histochemical, and interstitial pressure changes in the tibialis anterior muscle before and after aortofemoral bypass in patients with peripheral arterial occlusive disease
2002
Leg strength predicts mortality in men but not in women with peripheral arterial disease
2010
Friedreich‐like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the α‐Tocopherol transfer protein gene
1997
Inflammatory processes in amyotrophic lateral sclerosis
2002
Genetic and environmental risk factors for idiopathic inflammatory myopathies
2002
Inclusion body myositis and myopathies
1995 Standout
Myasthenia Gravis
2016 Standout
Long-term observational study of sporadic inclusion body myositis
2011
Management of acute organophosphorus pesticide poisoning
2007 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Calf Muscle Characteristics, Strength Measures, and Mortality in Peripheral Arterial Disease
2012
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis
1998 StandoutNobel
Progressive loss of cytochrome c oxidase in the human extraocular muscles in ageing — a cytochemical-immunohistochemical study
1992
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Aberrant RNA Processing in a Neurodegenerative Disease: the Cause for Absent EAAT2, a Glutamate Transporter, in Amyotrophic Lateral Sclerosis
1998
The propionyl-l-carnitine hypothesis: An alternative approach to treating heart failure
1997
Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche
2011 StandoutNobel
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
2013 Standout
From charcot to lou gehrig: deciphering selective motor neuron death in als
2001
Exercise Standards for Testing and Training
2013 Standout
Consensus guidelines for the design and implementation of clinical trials in ALS
1999
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Clinical aspects of ALS in Gulf War Veterans
2008
Leg strength in peripheral arterial disease: associations with disease severity and lower-extremity performance
2004
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Amyotrophic lateral sclerosis
2011 Standout
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
2011 Standout
Inflammatory myopathies: Clinical, diagnostic and therapeutic aspects
2003
Preliminary evidence that low ankle-brachial index is associated with reduced bilateral hip extensor strength and functional mobility in peripheral arterial disease
2012
Muscle fiber characteristics in patients with peripheral arterial disease
2001
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
1991 Standout
An Analysis of Extended Survival in Patients With Amyotrophic Lateral Sclerosis Treated With Riluzole
1998
Protein aggregation and neurodegenerative disease
2004 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Fatigue in amyotrophic lateral sclerosis: Frequency and associated factors
2008
Retinitis pigmentosa
2006 Standout
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Drug Antioxidant Effects
1991
Evidence of Compromised Blood-Spinal Cord Barrier in Early and Late Symptomatic SOD1 Mice Modeling ALS
2007
Diabetes and Atherosclerosis
2002 Standout
Diagnostic investigation and multidisciplinary management in motor neuron disease
2005
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study
2001 Standout
Treatment of Carbon Monoxide Poisoning: A Critical Review of Human Outcome Studies Comparing Normobaric Oxygen With Hyperbaric Oxygen
1994
Update on the genetics of the idiopathic inflammatory myopathies
2000
Inclusion body myositis
2007
Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles
2003 Standout
Carbon Monoxide Poisoning
1998 Standout
Eccentric Strength and Endurance in Patients with Unilateral Intermittent Claudication
2009
Vitamin E, antioxidant and nothing more
2007
Attitudes of Patients with Amyotrophic Lateral Sclerosis and Their Care Givers toward Assisted Suicide
1998
Dynamic muscle quality of the plantar flexors is impaired in claudicant patients with peripheral arterial disease and associated with poorer walking endurance
2015
Functional Decline in Peripheral Arterial Disease
2004
Resistance Training in Patients With Peripheral Arterial Disease: Effects on Myosin Isoforms, Fiber Type Distribution, and Capillary Supply to Skeletal Muscle
2001
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside
1988
Hyperbaric-Oxygen Therapy
1996 Standout
A systematic review of muscle morphology and function in intermittent claudication
2017 StandoutNobel
Cytochrome P450 ω-Hydroxylase Pathway of Tocopherol Catabolism
2002 Standout
Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis
1997 StandoutNobel
A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis
2002
The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy
1993
Novel drug development for amyotrophic lateral sclerosis
2000
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
1994 Standout
Intracellular amyloid-β in Alzheimer's disease
2007 Standout
Polymyositis and dermatomyositis
2003 Standout
Amyotrophic Lateral Sclerosis
2001 Standout
Amyloid Filaments in Inclusion Body Myositis
1991
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
1993 Standout
Isokinetic Strength and Endurance in Proximal and Distal Muscles in Patients With Peripheral Artery Disease
2012
Impairments of Muscles and Nerves Associated with Peripheral Arterial Disease and Their Relationship with Lower Extremity Functioning: The InCHIANTI Study
2004
Oxidative Stress Regulation of Stem and Progenitor Cells
2009
Lower Extremity Nerve Function, Calf Skeletal Muscle Characteristics, and Functional Performance in Peripheral Arterial Disease
2011
Oxidative damage and mitochondrial decay in aging.
1994 Standout
Amyotrophic lateral sclerosis
2000
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Clinical Trials in Motor Neuron Diseases
1999
Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease
1996
Polymyositis, Dermatomyositis, and Inclusion-Body Myositis
1991
Inflammatory Muscle Diseases
2015 Standout
Synthesis of Heterocycles via Electrophilic Cyclization of Alkynes Containing Heteroatom
2011 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review) [RETIRED]
2000
Progressive supranuclear palsy
1971
Bioisosterism: A Rational Approach in Drug Design
1996
Exercise for intermittent claudication
2014
Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals
2009
Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans.
1993
MOLECULAR MECHANISMS OF VITAMIN E TRANSPORT
1999
HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies
1998
Vitamin E: function and metabolism
1999
Myogenic Akt Signaling Regulates Blood Vessel Recruitment during Myofiber Growth
2002
Position Paper: Ipecac Syrup
2004
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Mitochondrial Diseases in Man and Mouse
1999 StandoutScience
Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review) [RETIRED]
1999
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Nonselective β-Adrenergic Blockade With Carvedilol Does Not Hinder the Benefits of Exercise Training in Patients With Congestive Heart Failure
1997
Pathophysiological Changes in Calf Muscle Predict Mobility Loss at 2-Year Follow-Up in Men and Women With Peripheral Arterial Disease
2009
Correlates of suffering in amyotrophic lateral sclerosis
1999
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Abnormal Accumulation of Desmin in Gastrocnemius Myofibers of Patients with Peripheral Artery Disease
2015
Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism.
1992
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Amyotrophic Lateral Sclerosis: Its Natural History
1987
Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study.
2000
Exercise for intermittent claudication
2017
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Excitotoxicity and Amyotrophic Lateral Sclerosis
2005
Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau.
1994
Novel Class of Potent 4-Arylalkyl Substituted 3-Isoxazolol GABAA Antagonists: Synthesis, Pharmacology, and Molecular Modeling
2002
Basic Science Review: The Myopathy of Peripheral Arterial Occlusive Disease: Part 2. Oxidative Stress, Neuropathy, and Shift in Muscle Fiber Type
2008
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Assessment of disease progression in motor neuron disease
2005
Increased atherosclerosis in hyperlipidemic mice deficient in α-tocopherol transfer protein and vitamin E
2000
Epidemiology of motor neuron disease in northern Sweden
1983
Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response.
1994
Inclusion-body myositis
2006
Works of S. P. Ringel being referenced
Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis
2001
Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis
1996
Spectrum of Inclusion Body Myositis
1987
A clinical trial of verapamil in amyotrophic lateral sclerosis
1996
Familial inclusion body myositis
1992
Isolated vitamin E deficiency in the absence of fat malabsorption--familial and sporadic cases: characterization and investigation of causes.
1988
Chronic changes in skeletal muscle histology and function in peripheral arterial disease.
1993
Sjogren's Syndrome and Polymyositis or Dermatomyositis
1982
The natural history of amyotrophic lateral sclerosis
1993
The ALS Patient Care Database
2000
Effects of selective and nonselective beta-adrenergic blockade on mechanisms of exercise conditioning.
1986
Drug Trial of Superoxide Dismutase in Duchenne's Muscular Dystrophy
1982
Quantitative Histopathology of the Inflammatory Myopathies
1986
Myopathy from surreptitious ipecac ingestion.
1986
Histochemistry of Human Extraocular Muscle
1978
The relationship of age to outcome in myasthenia gravis
1990
Friedreich's disease
1987
Carbon monoxide-induced Parkinsonism
1972
Effectiveness of Exercise in Progressive Neuromuscular Disease
1991
Abnormal adenine metabolism of erythrocytes in Duchenne and myotonic muscular dystrophy
1977 Nature
The Spectrum of Mild X-Linked Recessive Muscular Dystrophy
1977
The Diagnosis and Treatment of Amyotrophic Lateral Sclerosis
1981
Observations on the Efficacy of L-Dopa in Progressive Supranuclear Palsy
1971